Bionano Genomics (BNGO) EBITDA Margin (2017 - 2026)
Bionano Genomics recorded quarterly EBITDA Margin of 107.63% in Q1 2026, little changed quarter-over-quarter from 107.36% in Q4 2025, and up 1263.0% year-over-year from 7.9% in Q1 2025.
Bionano Genomics' EBITDA Margin history runs 10 years deep, the most recent figure standing at 107.63% for Q1 2026.
- In Q1 2026, EBITDA Margin rose 1263.0% year-over-year to 107.63%; the TTM figure through Mar 2026 stood at 111.6% (down 11104.0% YoY), while the FY2025 annual figure was 107.83%, down 4051.0% from the prior year.
- EBITDA Margin came in at 107.63% for Q1 2026 at Bionano Genomics, roughly flat from 107.36% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 839.46% in Q4 2024 to a low of 1214.98% in Q3 2023.
- A 5-year average of 314.36% and a median of 354.92% in 2024 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin soared 107221 bps in 2024 and sank 94682 bps in 2025, its largest moves.
- Bionano Genomics' EBITDA Margin stood at 456.81% in 2022, then soared by 49 bps to 232.75% in 2023, then surged by 461 bps to 839.46% in 2024, then plunged by 113 bps to 107.36% in 2025, then retreated by 0 bps to 107.63% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 107.63%, 107.36%, and 115.9% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 28.86% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 1.97% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 34.92% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 20.96% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 4.04% |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 19.85% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 13.65% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 2.44% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 17.48% |
| 10 | Bionano Genomics | 14.92 Mn | 539,417.67 | 3.25 Mn | -107.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -107.63% |
| Dec 31, 2025 | -107.36% |
| Sep 30, 2025 | -115.90% |
| Jun 30, 2025 | -115.85% |
| Mar 31, 2025 | -120.26% |
| Dec 31, 2024 | 839.46% |
| Sep 30, 2024 | -722.89% |
| Jun 30, 2024 | -218.99% |
| Mar 31, 2024 | -354.92% |
| Dec 31, 2023 | -232.75% |
| Sep 30, 2023 | -1,214.98% |
| Jun 30, 2023 | -452.99% |
| Mar 31, 2023 | -510.36% |
| Dec 31, 2022 | -456.81% |
| Sep 30, 2022 | -445.22% |
| Jun 30, 2022 | -480.94% |
| Mar 31, 2022 | -525.68% |
| Dec 31, 2021 | -456.73% |
| Sep 30, 2021 | -444.21% |
| Jun 30, 2021 | -427.28% |
| Mar 31, 2021 | -352.37% |
| Dec 31, 2020 | -278.85% |
| Sep 30, 2020 | -465.71% |
| Jun 30, 2020 | -629.02% |
| Mar 31, 2020 | -859.33% |
| Dec 31, 2019 | -256.74% |
| Sep 30, 2019 | -171.60% |
| Jun 30, 2019 | -314.67% |
| Mar 31, 2019 | -333.78% |
| Dec 31, 2018 | -151.95% |
| Sep 30, 2018 | -211.01% |
| Jun 30, 2018 | -118.35% |
| Mar 31, 2018 | -245.15% |
| Dec 31, 2017 | -184.15% |
| Sep 30, 2017 | -183.41% |